CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-30 | Hopkinson David G. Director | Option exercise | +124,378 | $0.61 | $76K | 335,563 |
| 2025-07-30 | Hopkinson David G. Director | Option exercise · Restricted Stock Units | −124,378 | 0 | ||
| 2025-07-30 | Clanachan David F Director | Option exercise | +124,378 | $0.61 | $76K | 236,880 |
| 2025-07-30 | Clanachan David F Director | Shares withheld for taxes | −65,921 | $0.61 | $40K | 170,959 |
| 2025-07-30 | Clanachan David F Director | Option exercise · Restricted Stock Units | −124,378 | 0 | ||
| 2025-07-30 | Persofsky Renah Director | Option exercise | +124,378 | $0.61 | $76K | 199,726 |
| 2025-07-30 | Persofsky Renah Director | Shares withheld for taxes | −65,921 | $0.61 | $40K | 133,805 |
| 2025-07-30 | Persofsky Renah Director | Option exercise · Restricted Stock Units | −124,378 | 0 | ||
| 2025-07-30 | Gendel Mitchell Global General Counsel | Option exercise | +243,781 | $0.61 | $149K | 777,345 |
| 2025-07-30 | Gendel Mitchell Global General Counsel | Shares withheld for taxes | −129,204 | $0.61 | $79K | 648,141 |
| 2025-07-30 | Gendel Mitchell Global General Counsel | Option exercise · Restricted Stock Units | −243,781 | 243,781 | ||
| 2025-07-30 | Merton Carl A Chief Financial Officer | Option exercise | +166,558 | $0.61 | $102K | 964,627 |
| 2025-07-30 | Merton Carl A Chief Financial Officer | Shares withheld for taxes | −88,276 | $0.61 | $54K | 876,351 |
| 2025-07-30 | Merton Carl A Chief Financial Officer | Option exercise · Restricted Stock Units | −166,558 | 166,558 | ||
| 2025-07-30 | SIMON IRWIN D President and CEO | Option exercise | +1,176,467 | $0.61 | $718K | 5,118,100 |
| 2025-07-30 | SIMON IRWIN D President and CEO | Shares withheld for taxes | −623,528 | $0.61 | $380K | 4,494,572 |
| 2025-07-30 | SIMON IRWIN D President and CEO | Option exercise · Restricted Stock Units | −1,176,467 | 1,176,467 | ||
| 2025-07-30 | SIMON IRWIN D President and CEO | Purchase | +165,000 | $0.61 | $100K | 3,941,633 |
| 2025-07-30 | Merton Carl A Chief Financial Officer | Purchase | +33,500 | $0.60 | $20K | 798,069 |
| 2025-07-29 | FALTISCHEK DENISE M Chief Strategy Officer | Grant or award · Restricted Stock Units | +1,873,707 | 1,873,707 |
Page 6 of 35 · 686 trades